PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland.\', \'University of Zurich, Zurich, Switzerland.\', \'Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland.\', \'Department of Dermatology, University Hospital Zurich, Zürich, Switzerland.\', \'Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.\', \'Division of Infectious Diseases and Children\'s Research Centre, University Children\'s Hospital Zurich, Zurich, Switzerland.\', \'Department of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, CH-8091, Zurich, Switzerland. michael.messerli@usz.ch.\', \'University of Zurich, Zurich, Switzerland. michael.messerli@usz.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00330-021-08122-2
?:doi
?:hasPublicationType
?:journal
  • European radiology
is ?:pmid of
?:pmid
?:pmid
  • 34156552
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.943
?:rankingScore_hIndex
  • 131
?:title
  • [18F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34156552>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34156552>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all